Back
Sonnet BioTherapeutics Holdings Quote, Financials, Valuation and Earnings
The dark truth about AI
Click here to learn more...
Sell
6
SONN
Sonnet BioTherapeutics Holdings
Last Price:
1.83
Seasonality Move:
-3.96%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)Sonnet BioTherapeutics Holdings Price Quote
$1.83
+0.06 (+3.39%)
(Updated: December 13, 2024 at 5:55 PM ET)
Sonnet BioTherapeutics Holdings Key Stats
Sell
6
Sonnet BioTherapeutics Holdings (SONN)
is a Sell
Day range:
$1.73 - $1.91
52-week range:
$1.66 - $18.72
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.62
P/B ratio:
0.44%
Volume:
351.3K
Avg. volume:
2.7M
1-year change:
-84.95%
Market cap:
$1.2M
Revenue:
$147.8K
EPS:
$-24.32
How Much Does Sonnet BioTherapeutics Holdings Make?
Data Unavailable
Is Sonnet BioTherapeutics Holdings Growing As A Company?
Data Unavailable
Sonnet BioTherapeutics Holdings Stock Price Performance
-
Did Sonnet BioTherapeutics Holdings Stock Go Up Last Month?
Sonnet BioTherapeutics Holdings share price went down by -41.97% last month -
Did SONN's Share Price Rise Over The Last Year?
SONN share price fell by -84.95% over the past 1 year
What Is Sonnet BioTherapeutics Holdings 52-Week High & Low?
-
What Is Sonnet BioTherapeutics Holdings’s 52-Week High Share Price?
Sonnet BioTherapeutics Holdings has traded as high as $18.72 over the past 52 weeks -
What Is Sonnet BioTherapeutics Holdings’s 52-Week Low Share Price?
Sonnet BioTherapeutics Holdings has traded as low as $1.66 over the past 52 weeks
Sonnet BioTherapeutics Holdings Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Sonnet BioTherapeutics Holdings?
-
How Much Debt Does Sonnet BioTherapeutics Holdings Have?
Total long term debt quarterly is $0 -
How Much Cash Does Sonnet BioTherapeutics Holdings Have?
Cash and short term investments quarterly total is $3.6M -
What Is Sonnet BioTherapeutics Holdings’s Book Value Per Share?
Book value per share is 4.01
Is Sonnet BioTherapeutics Holdings Cash Flow Positive?
-
What Is SONN Cash Flow From Operations?
Cash flow from operations (TTM) is -$10M -
What Is Sonnet BioTherapeutics Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is $6.7M -
What Is Sonnet BioTherapeutics Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Sonnet BioTherapeutics Holdings Return On Invested Capital
Data Unavailable
Sonnet BioTherapeutics Holdings Earnings Date & Stock Price
-
What Is Sonnet BioTherapeutics Holdings's Stock Price Today?
A single share of SONN can be purchased today for 1.77 -
What Is Sonnet BioTherapeutics Holdings’s Stock Symbol?
Sonnet BioTherapeutics Holdings trades on the nasdaq under the ticker symbol: SONN -
When Is Sonnet BioTherapeutics Holdings’s Next Earnings Date?
The next quarterly earnings date for Sonnet BioTherapeutics Holdings is scheduled on December 13, 2024 -
When Is SONN's next ex-dividend date?
Sonnet BioTherapeutics Holdings's next ex-dividend date is December 13, 2024 -
How To Buy Sonnet BioTherapeutics Holdings Stock?
You can buy Sonnet BioTherapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Sonnet BioTherapeutics Holdings Competitors
-
Who Are Sonnet BioTherapeutics Holdings's Competitors?
Below is a list of companies who compete with Sonnet BioTherapeutics Holdings or are related in some way:
Sonnet BioTherapeutics Holdings Dividend Yield
-
What Is SONN Dividend Yield?
Sonnet BioTherapeutics Holdings’s dividend yield currently is 0% -
What Is Sonnet BioTherapeutics Holdings’s Payout Ratio?
Sonnet BioTherapeutics Holdings’s payout ratio is 0% -
When Did Sonnet BioTherapeutics Holdings Last Pay A Dividend?
The latest dividend pay date is December 13, 2024 -
What Is Sonnet BioTherapeutics Holdings’s Dividend Per Share?
Sonnet BioTherapeutics Holdings pays a dividend of $0.00 per share
Sonnet BioTherapeutics Holdings Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 8.5% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 240.00 |
| Upside from Last Price: | 13459.32% |